LogicBio Therapeutics, Inc.

Home » LogicBio Therapeutics, Inc.

IPO

LogicBio Therapeutics, Inc.

We are a genome editing company focused on developing medicines to durably treat rare diseases in patients with significant unmet medical need using GeneRide, our proprietary technology platform.

Symbol

LOGC

Price Range
$12.00 - $14.00

Final Shares
5,770,000

Anticipated Date
TBD

Underwriters
Jefferies, Barclays, William Blair, Chardan

To view the prospectus for LogicBio Therapeutics, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253